Nevia Bio uses vaginal fluid—not blood—to detect gynecologic cancers earlier and more accurately. By analyzing the fluid nearest to the tumor site, rather than waiting for cancer DNA to appear in blood, we aim to uncover disease much sooner.
Our test is designed for self-collection, eliminating the need for blood draws, clinical visits, or invasive procedures. The result: earlier and more accurate detection, with lower cost and higher convenience